Why the study?
Dilated cardiomyopathy may rarely be complicated by left ventricular thrombi, which carry a significant risk of systemic embolization.
Prompt anticoagulation and guideline-directed medical therapy can lead to complete resolution of left ventricular thrombi and favorable remodeling in patients with dilated cardiomyopathy and BAG3 mutation.
No takes yet. Share an insight, caveat, or question.
Supports anticoagulation and GDMT in BAG3 cardiomyopathy with thrombi; hypothesis-generating for genetic DCM.
Iorgi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: